House GOP budget spares bank insurance fund
Indiana bankers are relieved House Republicans decided to spare a bank insurance fund from being raided to plug holes elsewhere in the state’s finances, but they’re not done lobbying against the idea.
J.K. Wall
Articles
Financier in botched deal sues Emmis over loan to Smulyan
In uncommonly sharp language, attorneys for New York-based Alden Global Capital accused Emmis' board of “a blatantly self-dealing transaction” that allows Smulyan to “pursue a personal litigation vendetta” against Alden.
Emerging markets give Lilly hope in patent crunch
In a kind of alternate drug universe, sales of Eli Lilly and Co.’s ghosts of blockbusters past are soaring in China—prompting the drugmaker to pour money into emerging markets in an attempt to prop up revenue.
Thousands of IU Health patients getting hotel-stay discounts
A program to help Indiana University Health patients get discounted hotel rooms has ballooned in recent years to the size of a midsize convention.
St. Vincent CEO takes on new duties in Wisconsin
St. Vincent Health CEO Vince Caponi will take charge of three hospitals in Wisconsin that are also owned by St. Vincent’s parent organization, Ascension Health. He’ll also keep his current job.
Q&A
Harlon Wilson, president of Indianapolis-based Medical Animatics, says the uncertainty created by the recession and now health care reform have dried up most opportunities for his 3-D animation firm to win new business with health care clients. So he’s looking at new markets—such as the recent online learning work for Harrison College that led Medical Animatics to sell some of its assets to the for-profit university. And Wilson is still banking on persistent needs to educate patients to cause health care to bounce back.
Fort Wayne firm to open health info to patients
With electronic medical record systems proliferating, there’s information galore about patients. But it’s not so easy for patients to get at it. Now Fort Wayne-based NoMoreClipboard has been charged to design ways to fix that problem.
Reform, revenue behind Franciscan expansion
Changes unleashed by health reform are pushing Franciscan St. Francis Health’s expansion into Hamilton County—in addition to the obvious pull of the area’s well-heeled population.
Diabetes boom sparks Roche expansion
Roche Diagnostics Corp. is expanding one of its Indianapolis manufacturing plants to keep up with growing sales of its leading brand of blood glucose monitors.
Medicaid expansion could tax community health centers
The president of the Indiana Primary Health Care Association wants to double the number of federally qualified community health centers in Indiana in the next five years.
Daniels leads guvs’ health-care revolt
Boy does Gov. Mitch Daniels have an ultimatum for President Obama: Wave off the health reform law or else I’ll do nothing to help while it wreaks havoc on Hoosier citizens.
Recent successes don’t change Lilly’s outlook
Eli Lilly and Co. can be credited with using acquisitions to unclog its product pipeline. It launched two drugs in the past 18 months, won market approval for a third and will likely get nods for two more drugs this year. Trouble is, they all have paltry sales prospects.
2010 compensation fell about 20 percent for top Lilly execs
Compensation for Eli Lilly and Co.’s top executives fell last year due to a change to its stock award program and as the company struggled to bring new medicines to market.
Health insurance brokers set for shakeout
Health insurance brokers, who match up employers with health insurance policies, are about to have a brighter light shone on the commissions they earn from insurers. The likely result: Commissions will fall or flatline and, eventually, fall away in favor of fee-based business models.
Lilly, Bristol-Myers halt enrollment in lung-cancer trial
Eli Lilly and Co. and Bristol-Myers Squibb Co. stopped enrolling new patients in a clinical trial of an experimental lung cancer drug over concerns about patients developing blood clots.
Marcadia may fetch up to $537 million in sale
The December sale of Carmel-based Marcadia Biotech to Roche garnered at least $287 million—and as much as $537 million—for the company’s owners and could lead the Marcadia management team to launch a firm using one of Marcadia’s experimental diabetes medicines.
Judge’s ruling raises uncertainty for health care execs
After a federal judge in Florida struck down the entire health reform law, investors shrugged. But the uncertainty for executives in health care companies increased.
Charter school’s nimble approach could become the norm
Indianapolis Metropolitan High School implemented a school-wide overhaul in its educational approach in only three months. The charter school might be the face of the future for all Indiana public schools.
Lilly’s fourth-quarter profit surges, topping analysts’ predictions
The Indianapolis-based drugmaker earned $1.2 billion in the quarter, compared with $915 million in the same period a year ago. Profit per share beat Wall Street forecasts by a penny.
WellPoint profit better than analyst estimates
Excluding special charges, WellPoint’s profit fell 2 percent to $524.7 million in the fourth quarter from $536 million in the fourth quarter of 2009. But earnings per share improved thanks to stock buybacks.